Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment
Develops treatments to rejuvenate vision in the aging eye
Provides rapid access to functional proteins through benchtop eProtein Discovery System
Pitching British Business Bank? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room